SMART Modular Technologies Releases New PCIe NVMe Solid State Drives
Delivering PCIe Gen 4.0 compatibility, SMART’s new T6CN family of SSDs offers high-performance, cost-competitive solutions…
Delivering PCIe Gen 4.0 compatibility, SMART’s new T6CN family of SSDs offers high-performance, cost-competitive solutions…
Audiences at ISG Future Workplace Summits vote for tech startups that measure digital workforce productivity,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
SMBs Can Now Deliver More than Just Powerful Wi-Fi HSINCHU, Taiwan–(BUSINESS WIRE)–Edgecore Networks, a leading…
IETF members and new SCITT Community look to drive real-world implementations of IETF SCITT specifications…
TREK-AD Phase 2b study of eblasakimab fully enrolled, topline data readout expected early July 2023…
atai’s development candidates, such as RL-007 and GRX-917, all represent significant opportunities to address unmet…
Oslo, 24 March 2023, the Board of Directors hereby calls for the Annual General Meeting…
Signed a collaboration agreement with BioNTech to develop and commercialize immunomodulatory small molecule therapeutics; deal…
Dr. Ryan Looper, a chemistry Professor at the University of Utah, sat down with CancerVAX…
Oslo, 24 March 2023: Ultimovacs ASA (“Ultimovacs”, ticker ULTI), a clinical-stage biotechnology leader in novel…
LONDON and NEW YORK, March 24, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO;…
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders…
MONT-SAINT-GUIBERT, Belgium, March 24, 2023 (GLOBE NEWSWIRE) — Celyad Oncology (Euronext & Nasdaq: CYAD) (the…
Emmanuel Hanon, PhD, will chair the company’s scientific advisory board. Professor Peter Piot (MD, PhD)…
NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the…
Starting in 2023, Celyad Oncology is now entirely focused on its new business strategy with…
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the…
Daix (France), Long Island City (New York, United States), March 23, 2023 – Inventiva (Euronext…
RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor…